Michael Birnbaum is an Associate Professor of Biological Engineering at MIT. His research focuses on T cell biology and engineering.During his tenure at the Koch Institute, Birnbaum has received the AACR-TESARO Career Development Award for Immuno-oncology Research, aPackard Fellowship in Science and Engineering, a Pew-Stewart Scholarship for Cancer Research, a V Scholar Grant from the Jimmy V Foundation, the Michelson Prize for Human Immunology and Vaccine Research, and the Damon Runyon-Rachleff Innovator Award. In October 2020, he received the National Institutes of Health (NIH) New Innovators Award. He is a co-founder of Kelonia Therapeutics and Abata Therapeutics, and is an advisor for both.

Talks

• High-Density Microbioreactor Process Designed for Automated Point-Of-Care Manufacturing of CAR T Cells